Aleva Neuro
Overview
Aleva Neurotherapeutics SA is a company specializing in neuromodulation treatments, headquartered in Lausanne, VD. The company introduced Directional Deep Brain Stimulation (DBS) technology, which has set the industry standard for directional leads. Aleva has begun its commercial journey following the CE marking of its directSTIM™ device, partnering with major neurological clinics in Germany and aiming to expand into other European markets. Aleva is the only European company that designs, manufactures, and commercializes DBS devices specifically for treating Parkinson’s disease and essential tremor. Its production and research and development headquarters in Switzerland adhere to high-quality standards to ensure patient safety.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Lausanne, VD
- Type
- Privately Held
- Founded
- 2013
- Followers
- 5,198
- Specialties
- Neurosurgery, Deep Brain Stimulation, and Medical Device Development
- Locations
- EPFL Innovation Park, Building D Lausanne, VD 1015, CH
Funding
Total rounds: 9
Last round: Corporate round, Aug 9, 2021